Privium Fund Management B.V. Alx Oncology Holdings Inc Transaction History
Privium Fund Management B.V.
- $436 Million
- Q4 2024
A detailed history of Privium Fund Management B.V. transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Privium Fund Management B.V. holds 509,059 shares of ALXO stock, worth $539,602. This represents 0.19% of its overall portfolio holdings.
Number of Shares
509,059
Previous 509,059
-0.0%
Holding current value
$539,602
Previous $926,000
8.21%
% of portfolio
0.19%
Previous 0.23%
Shares
2 transactions
Others Institutions Holding ALXO
# of Institutions
96Shares Held
39.5MCall Options Held
213KPut Options Held
44.8K-
Ven Bio Partners LLC San Francisco, CA9.7MShares$10.3 Million13.33% of portfolio
-
Redmile Group, LLC San Francisco, CA3.69MShares$3.91 Million0.48% of portfolio
-
Tang Capital Management LLC San Diego, CA3.3MShares$3.49 Million0.41% of portfolio
-
Black Rock Inc. New York, NY2.69MShares$2.85 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.5MShares$2.65 Million0.0% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $43.2M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...